Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey

Canna Clinical TrialsLeave a comment

Governmental debate in Ireland on the de facto decriminalisation of cannabis and legalisation for medical use is ongoing. A cannabis-based medicinal product (Sativex®) has recently been granted market authorisation in Ireland. Male GPs and those with higher levels of addiction training are more likely to support a more liberal drug policy approach to cannabis for personal use.

Adult-use marijuana bill carefully crafted to make new industry, Maine communities safer

Cannabis newsLeave a comment

Failure to support the proposal will allow flawed aspects of the original referendum to take effect, says Falmouth Rep. Teresa Pierce. Last November, Maine citizens narrowly passed a referendum to legalize the adult use of recreational marijuana. Once that referendum was passed, the Legislature was tasked with the critical, and considerable, responsibility of implementing the…

Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review

Canna Clinical TrialsLeave a comment

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disorder of the central nervous system (CNS) that can cause cognition, mobility, and sensory impairments. It is considered one of the most common non-traumatic causes of disability in the world. The aim of the present article was to review the clinical evidence related to medicinal plants in the management of MS symptoms.

The Current Landscape of Marijuana and Pharmacogenetics

Canna Clinical TrialsLeave a comment

The treatment of medical conditions with cannabis and cannabinoid compounds is advancing. Although there are numerous reports related to the genetic variations of the cannabinoid receptor, a lack of studies that examine the relationship between other pharmacogenetic markers and health outcomes currently exists. Legalisation of marijuana is needed in order to perform more randomised controlled trials to help elucidate the role of other pharmacogenetic targets and cannabis for use in clinical practice.